DRReddy’s consolidated revenue increased by 7% QoQ to INR 67,579 Mn (+35% YoY ). The company reported a YoY revenue growth, driven increase in North America generics sales, The North America generics revenue stood at USD 390 Mn. The growth in this region was mainly driven by growth in gRevlimid sales.